DUBLIN–(BUSINESS WIRE)–The “Indonesia Existing & Upcoming Data Center Portfolio” report has been added to ResearchAndMarkets.com’s offering.
The upcoming data center capacity in Indonesia is over 950 MW on full build, which is almost two times the country’s current existing capacity. DCI Indonesia is the largest data center Operator in the region, followed by Indosat Ooredoo Lintasarta & BDx and Telkom Indonesia.
Jakarta dominates Indonesia’s upcoming data center market with almost 40% of the total power capacity. Almost 45% of the existing Rack capacity is concentrated around Jakarta.
Key Market Highlights:
This database (Excel) product covers the Indonesia data center market portfolio analysis, which will provide the following information on the colocation data centers:
The data points covered in the database across each facility are mentioned below:
Existing Data Centers (79 Facilities):
Upcoming Data Centers (24 Facilities):
Target Audience:
Key Topics Covered:
Investors/Operators Covered
For more information about this report visit https://www.researchandmarkets.com/r/ucllfj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
DUBLIN--(BUSINESS WIRE)--The "Japan RegTech Business and Investment Opportunities Databook - 50+ KPIs on RegTech Market…
BEIJING--(BUSINESS WIRE)--#AwusiqiRanch--"My China Story" International Short Video Competition, starting in 2018, is an annual event…
HAIKOU, CHINA – Media OutReach Newswire – 28 November 2024 - Department of Tourism, Culture,…
CHANGDU CITY, CHINA - Media OutReach Newswire - 28 November 2024 - Taking its source…
Only immuno-oncology drug approved by various regulatory authorities around the world such as the USFDA,…
HANGZHOU, China--(BUSINESS WIRE)--Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988…